BMRN
BioMarin Pharmaceutical
$60.00
▼ -0.03%
−$0.02
NYSE · Healthcare · Biotechnology
· price updated 9h ago
BioMarin Pharmaceutical
BMRN · NYSE · Healthcare · Biotechnology · price updated 9h ago
$60.00
▼ -0.03% · −$0.02 today
AI research · $60.00
Track BMRN for continuous AI research
price position
Where BMRN sits now
52-week range
Low$49.26
High$66.28
Today $60.00
RSI (14)
57.6Neutral
03070100
fundamentals
Business quality and valuation
Operating record
What the business has actually produced
Revenue
Capital structure
Cash versus debt
Cash & investments$2.2B
Total debt$1.4B
Net cash after debt$792.1M
Valuation
What the market charges
Forward P/E
Price against expected earnings
Favorable · 50% below Sector avg · favorable
10.69x
Price / sales
Value assigned to each sales dollar
Reasonable · Between 3x and 8x sales
3.58x
Price / FCF
Price against free cash generation
Strong · Under 20x free cash flow
15.12x
EV / EBITDA
Operating value including debt
Rich · Above 22x EBITDA
27.80x
Quality
How efficiently it compounds
ROIC
Return earned on invested capital
Weak · Below 8% return on capital
7.4%
ROE
Profit generated from shareholder equity
Needs attention · Among weakest in sector
4.5%
Debt / equity
Balance-sheet leverage
Favorable · Exceptional vs sector peers
0.23x
Current ratio
Short-term assets against liabilities
Strong · Comfortable short-term liquidity
5.81x
Selected financial data sourced from StockAnalysis and refreshed weekly. Figures may be delayed and are for research context, not investment advice.
peer comparison
How BMRN compares
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| $11.60B | 43.8 | +9.9% | 63 |
 | $10.69B | 18.4 | +23.5% | 78 |
 | $4.88B | 20.3 | +10.3% | 77 |
 | $31.49B | 32.9 | +15.5% | 77 |
 | $1.08T | 41.4 | +47.4% | 76 |
US stock research
About BioMarin Pharmaceutical (BMRN) stock
BioMarin Pharmaceutical tracked in the US core universe. BMRN was -0.0% in the latest available session at $60.00. Its reported market value was $11.60B with a trailing P/E of 43.8. Latest reported revenue was $3.24B, changing +9.9% year over year, with $268.74M in net income.
Market snapshot updated Aug 3, 2026, 7:59 PM UTC.
- Latest available price
- $60.00
- Day change
- -0.0%
- Market cap
- $11.60B
- P/E (TTM)
- 43.8
- Revenue growth
- +9.9%
- Industry
- Biotechnology